MESHINE by MagneD Launches AI-Powered Dermatology Diagnostic System, Targeting Public Hospital Aesthetic Upgrades

At this press conference, Yang Ruijia, Chairman of Medlander Group, broke down the company's strategy into two clear directions: health, more rigorous; beauty, more consumer-oriented.These two directions are not disconnected; rather, they share the same underlying foundation—the medical attributes of safety and efficacy.

Based on this cornerstone, Medlander has developed a matrix of six core solutions:AI-driven physical rehabilitation intervention solutions for the full female life cycle, women's gynecological and postoperative solutions, reproductive aesthetics, skin aesthetics, body contouring, and psychological well-being. These six solutions are not independent business units, but rather an integrated synergistic system centered on the "full female life cycle".

Mr. Yang distilled it into a single sentence: “It begins with the mucosa, centers on the pelvic floor muscles, is sustained by the ovaries, rooted in qi and blood, and manifests in facial appearance.” From pelvic floor conditions encompassing urinary incontinence, pelvic organ prolapse, fecal incontinence, pain, and sexual dysfunction to reproductive anti-aging, from AI-integrated dermatological diagnosis and treatment to body contouring management, and further to brain-computer interfaces combined with psychological therapy,Medlander's strategic blueprint clearly points to a single objective: covering all key nodes in women's health and beauty.

Within this strategic landscape, Meixian’s mission is to implement the integration of AI-assisted dermatological diagnosis and treatment. The core platform for this implementation is precisely the AI Dermatology Diagnosis and Treatment System unveiled herein.This system does not exist in isolation but rather serves as the concrete implementation of the "Facial and Body Anti-aging" tier within Medlander's "Four-Tier Anti-aging System"—the tiers above it are the mucosa and pelvic floor (foundational defense tier) and the ovaries and Qi and Blood (core regulatory tier); the peer tier is body management, and the lower tier is psychological aesthetic healing. Skin conditions are never isolated; endocrine status, pelvic floor health, and emotional fluctuations all influence skin manifestations.The fundamental reason why Meixian's system can transcend mere "equipment stacking" is that it is backed by Medlander's comprehensive women's health ecosystem.

In his speech, Zhu Bisheng, General Manager of Medlander Weizhilan & Meixian, proposed a core breakthrough strategy:Redefining Boundaries, Breaking Through for Win-Win — Driven by the "Department of Medical Aesthetics," Reshaping the Comprehensive Anti-Aging Clinical Workflow.This is not merely about addressing pain points, but rather upgrading fragmented equipment procurement into operationally viable departmental capacity building.

To this end, President Zhu announced four supporting systems at the event:

Driven by the Department of Medical Aesthetics, multidisciplinary resources across obstetrics and gynecology, dermatology, traditional Chinese medicine, and rehabilitation are integrated to establish an integrated service model of "Health First, Beauty Follows."

Covers in-hospital patient flow capture, on-site clinical coaching for conversion, and deep cultivation and activation of private-domain channels. This is not a "sell equipment and leave" model; rather, it addresses the operational pain points of public hospitals: "possessing equipment but lacking commercialization expertise, and holding clinical technologies but lacking the ability to effectively communicate their value."

Standardized training is delivered in phases, covering equipment operation, treatment protocol design, and doctor-patient communication. Within 0–3 months post-installation, basic clinical application is completed; after 3 months, training advances to intermediate application and hands-on technique instruction, establishing a sustainable talent pipeline.

Leveraging existing resources for a low-cost launch, this initiative renovates and upgrades currently underutilized spaces within the hospital. This design addresses the practical dilemma faced by public hospitals of "having available space but lacking a clear utilization strategy."

“Steadfast Execution Breaks New Ground, Pragmatic Implementation Drives Win-Win Results”——General Manager Zhu Bisheng used these eight characters to encapsulate the core philosophy of this support system. Concurrently, he announced the official launch of the recruitment program for the first batch of Core City Partners for the “Women's Holistic Anti-Aging Centers,” marking Meixian's transition from “solution rollout” to a new phase of “implementation partnerships.”

The breakthrough logic addresses the question of “how to implement it,” while upgrading from experience-based practice to standardized diagnosis and treatment requires a comprehensive AI technology pathway—this is the core of Medlander's Meixian Skin AI Diagnosis and Treatment System.

In his presentation, Zhou Ding, Head of Skin Products at Medlander Meixian, systematically detailed Medlander Meixian’s comprehensive digital skin anti-aging solution powered by AI. The core technical logic of this framework can be summarized in just six characters:Assess first, then treat.

Facial aging is not a single-layer issue; from the skeletal framework to soft tissues and the skin, each anatomical layer manifests distinct changes, necessitating differentiated intervention strategies. However, under traditional clinical models, the assessment phase is severely compressed, leading to "unclear diagnosis, imprecise treatment, and unstable outcomes." Traditional operational paradigms exhibit five characteristics—experience-driven, perception-based, intuition-guided, tool-dependent, and physician-centric—ultimately making therapeutic efficacy highly contingent upon individual practitioner expertise.

Meixian's systematic solution restructures the clinical pathway into three standardized steps:

Multispectral imaging, 48-megapixel resolution, 30-second automatic full-face scanning, and 0.2mm-precision 3D modeling generate 13 imaging modes, digitizing layered information such as pigmentation, vasculature, inflammation, and facial contours. Assessment is no longer about "what it looks like," but rather an objective, quantitative baseline.

Fascial layer lifting utilizes an HIFU device (25-level depth transducers, 4 ms ultra-pulse, CFUS adaptive algorithm), muscular layer remodeling employs the JiSuJi muscle sculpting system (4000 Hz premium variable-frequency particle flow, 2.4 million passive contractions per session), and epidermal/dermal pigmentation, texture, and scars are comprehensively addressed by a laser matrix (Meixian Ultra Q-Light / Meixian Star Diamond Super Photon / Meixian Star Radiance Fractional Laser).

The Meixi Analysis Device supports three comparison modes—split-screen, mirror-image, and historical—forming a traceable closed loop of "treatment–evaluation–adjustment"; the Meixian Ultrasonic Scalpel achieves true interoperability, generating digitized patient profile records during treatment to ensure every procedure is fully documented and traceable.

The essence of these three steps is to implement the upgrade from “experience-based → visualized, sensation-based → precise, subjective → data-driven” into specific product portfolios and standardized workflows.The technological foundation underpinning this system is built upon Medlander’s over a decade of accumulated expertise in multi-dimensional diagnostic and therapeutic technologies—including acoustic, optical, electrical, thermal, magnetic, and imaging modalities—along with extensive service experience across more than 15,000 institutions.

Returning to a fundamental question: Why should public hospitals pay attention to this system?

The data provides a clear answer. On the demand side,In 2025, the medical aesthetics market size reached 350 billion RMB, with non-surgical medical aesthetics accounting for 75%. Anti-aging consumption has evolved from an "annual overhaul" to "quarterly maintenance."Supply side,In 2025, over 30,000 private medical aesthetics institutions were deregistered or shut down, with more than 60% of aesthetic consumers listing “institutional compliance and legitimacy” as their primary criterion. Meanwhile, across China, a total of 203 public hospitals established or officially inaugurated medical aesthetics-related departments in 2025, representing a year-on-year surge of 229%. Additionally, over 60% of Grade III Class A hospitals nationwide have already expanded into non-medical-insurance-covered services.

Public hospitals enter the market, but face three practical shortcomings:Diagnosis relies on clinical experience and treatment depends on standalone devices, lacking intelligent, integrated "assessment + treatment" solutions; dermatology and gynecology operate in strict silos, lacking a holistic anti-aging perspective; facility development relies on mere equipment stacking without standardized diagnostic and treatment pathways, making clinical efficacy dependent on individual experience and difficult to replicate or subject to quality control.

Meixian's AI-driven skin diagnosis and treatment system serves as a systematic solution precisely addressing these three shortcomings. Furthermore, the implementation model of the "Women's Comprehensive Anti-Aging Center" further transforms the "system" into "operational departmental capabilities."

The underlying cornerstone of "safety and efficacy" as a core medical attribute, as emphasized by Chairman Yang Ruijia in his speech, is precisely the greatest comparative advantage of public hospitals. The deeper the trust crisis confronting private healthcare institutions, the more pronounced the compliance value of public hospitals becomes.Meixian provides public hospitals with a capability foundation that transforms this advantage into sustainable revenue.

Furthermore, Medlander is advancing the “Standardized Construction of Women's Anti-Aging Centers” project in collaboration with the Chinese Maternal and Child Health Association, formulating the 《Guidelines for the Construction and Management of Women's Anti-Aging Centers》, establishing a tiered classification system for anti-aging technologies, and promoting the “1+N” service model (1 attending physician + N specialist support). This means thatMedlander's system is not only a commercial solution, but is also poised to become a participant in shaping industry standards.

Over the past decade, competition in China's aesthetic dermatology equipment market has centered on the technical specifications and pricing of individual devices, with "selling equipment" as the mainstream business model.The essence of Medlander's latest release lies in elevating the competitive dimension from "devices" to "systems"—the core is no longer the technical specifications of a single ultrasonic scalpel or laser, but rather the comprehensive closed-loop capability spanning assessment, treatment, and management. Underpinning this is Medlander's holistic ecosystem, which encompasses pelvic floor rehabilitation, reproductive rejuvenation, skin management, body contouring, and psychological therapy.

As public hospitals expand into the medical aesthetics sector, the true barrier lies not in equipment procurement, but in the systematic development of clinical diagnostic and treatment capabilities. Meixian’s AI-powered dermatological diagnostic and therapeutic system provides a replicable pathway for capacity building within public medical aesthetics.As 203 public hospitals flood into this sector in 2025, whoever first establishes a standardized and quality-controlled diagnosis and treatment system will seize the initiative.

Medlander's choice is: to no longer ask "how many devices have been sold," but instead ask "how many clinical departments have been integrated with the system." The answer to this question will define the company's future more profoundly than any sales figures.This is not a "sexy" narrative, but it may be the most pragmatic and correct answer at present.

Founded in 2013 and listed on the STAR Market of the Shanghai Stock Exchange in 2022 (Stock Code: 688273), Medlander is a leading enterprise in China providing intelligent pelvic floor and reproductive rehabilitation diagnostic and treatment systems and solutions. Its equipment serves over 15,000 institutions, covering major provinces and municipalities across China.

A high-end medical aesthetics brand under Medlander, specializing in skin anti-aging and health management, dedicated to developing AI-integrated diagnosis and treatment · comprehensive facial rejuvenation solutions.

For anti-aging, choose Meixian; youth without limits.